GBA1 and Gaucher disease: Disturbances in glucosylceramidase activity have been implicated in the pathogenesis of Gaucher disease, an LSD characterized by the accumulation of GlcCer and other sphingolipids in multiple tissues and organs (Futerman and Platt, 2017).